Last reviewed · How we verify

NCT05392920

Determination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and Adolescents

Status unknown Last updated 8 July 2022
What this trial tests

trial testing assessment study in Obese in 28 participants. Status unknown.

Timeline
8 July 2022
Primary endpoint
2 October 2022
2 November 2022

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment28
Start date8 July 2022
Primary completion2 October 2022
Estimated completion2 November 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 8 to 18, any sex, with Obese or Child Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obese individuals need to be evaluated comprehensively before exercise programs are determined. Determination of exercise intolerance is important for the detection of functional limitations. One minute sit to stand test (1MSTST) can be used as an alternative to cardiopulmonary exercise tests (CPET) or field tests. It is easy to use, quick to apply, valid and reliable, and applicable even in small areas. In addition, it is a simple assessment adequate for children's needs and behaviors and can be easily applied both in the clinic and at home, making it easier to use in children. Studies have shown that 1MSTST is a valid test in chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung disease, and, healthy children and adolescents. However, no study has been found regarding the validity of its use in obese children and adolescents.The aim of our study is to investigate the validity and reliability of 1MSTST in overweight-obese children and adolescents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obese

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05392920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing